Yang Watkin Phoebe L. 4

4 · GE HealthCare Technologies Inc. · Filed May 11, 2026

AI-generated summary of this filing

Updated May 12, 2026

GE HealthCare Director Phoebe L. Yang Buys Stock, Receives RSUs

What Happened

Phoebe L. Yang (listed in the filing as Yang Watkin Phoebe L.), a director of GE HealthCare Technologies Inc. (GEHC), received an award of 3,586 restricted stock units (RSUs) on May 7, 2026 (acquisition price $0.00) and made an open‑market purchase of 1,000 shares on May 8, 2026 at a weighted average price of $63.01 for a total cash outlay of $63,006. The award is a grant of RSUs (not an immediate cash payment).

Key Details

Transactions: RSU award of 3,586 RSUs on 2026-05-07 (price reported $0.00); open‑market purchase of 1,000 shares on 2026-05-08 at a weighted avg. $63.01 ($62.97–$63.01 range).
Total cash spent on purchase: $63,006.
Shares owned after the transactions: not specified in the provided filing details.
Footnotes: F1 — 100% of the RSUs vest on the earlier of GE HealthCare’s next annual meeting or May 7, 2027; settlement of vested RSUs may be deferred under the director deferral plan. F2 — each RSU equals one share at settlement. F3 — purchase price is a weighted average; purchases occurred at prices between $62.97 and $63.01.
Filing/timeliness: Form 4 was filed on 2026-05-11 for transactions on 2026-05-07 and 2026-05-08; the filing appears timely.

Context

RSUs are a compensation award that convert to shares at settlement (subject to vesting and any deferral election). The open‑market purchase is a straightforward buy (cash purchase); purchases by insiders can be interpreted as the insider acquiring equity but do not by themselves prove intent or future performance.

Form 4

Period: 2026-05-07

Director

Transactions

Award
Common Stock, par value $0.01 per share
[F1][F2]
2026-05-07+3,586→ 12,702 total
Purchase
Common Stock, par value $0.01 per share
[F3]
2026-05-08$63.01/sh+1,000$63,006→ 13,702 total

Footnotes (3)

[F1]Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
[F2]Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
[F3]The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Signature

/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact|2026-05-11

1 file